Transcranial sonography and 123I-FP-CIT single photon emission computed tomography in movement disorders

Ultrasound in Medicine and Biology

Volumn 40, Issue 10, 2014, Pages 2365-2371

  Bártová, Petra ^a   Kraft, Otakar ^a   Bernátek, Jaromír ^b   Havel, Martin ^a   Ressner, Pavel ^a   Langová, Kateřina ^c   Herzig, Roman ^d   Školoudík, David ^a,c  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b Krajska Nemocnice T Bati as   (Czech Republic)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Parkinson's disease; Parkinsonian syndromes; Single photon emission computed tomography; Substantia nigra; Transcranial sonography; 123I ioflupane

Indexed keywords

DIAGNOSIS; DISEASES; NEURODEGENERATIVE DISEASES; PARTICLE BEAMS; PHOTONS; TOMOGRAPHY; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

PARKINSON'S DISEASE; PARKINSONIAN SYNDROMES; SUBSTANTIA NIGRA; TRANSCRANIAL SONOGRAPHY; [123I]IOFLUPANE;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

IOFLUPANE I 123; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; RADIOPHARMACEUTICAL AGENT; TROPANE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOGRAPHY; ESSENTIAL TREMOR; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MIDDLE AGED; MOTOR DYSFUNCTION; NEUROIMAGING; PARKINSON DISEASE; PARKINSONISM; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOGENIC MOVEMENT DISORDER; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; AGED; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; PROCEDURES; SCINTISCANNING;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84926211220     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2014.05.014     Document Type: Article

References (34)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-IV-TR) 2000, Author, Washington, DC. 4th ed.
2. Bain P., Brin M., Deuschl G., Jankovic J., Findley L., Koller W.C., Pahwa R. Criteria for the diagnosis of essential tremor. Neurology 2000, 54(11, Suppl 4):S7.
3. Bártová P., Skoloudik D., Fadrna T., Ressner P., Kanovsky P., Herzig R. Sonographic evaluation of substantia nigra in parkinsonian syndromes. Parkinsonism Relat Disord 2007, 13(Suppl 2):149.
4. Bártová P., Školoudík D., Ressner P., Herzig R., Kaňovský P. Correlation between substantia nigra features detected by sonography and Parkinson's disease symptoms. JUltrasound Med 2010, 29:37-42.
5. 123I]-FP-CIT study group. Mov Disord 2000, 15:503-510.
6. Benamer H.T.S., Patterson J., Wyper D.J., Hadley D.M., Macphee G.J., Grosset D.G. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord 2000, 15:692-698.
7. Berg D., Becker G., Zieler B., Tucha O., Hofmann E., Preier M., Benz P., Jost W., Reiners K., Lange K.W. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999, 53:1026-1031.
8. 123I]FP-CIT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease. Synapse 2001, 39:101-108.
9. Bouwmans A.E., Vlaar A.M., Mess W.H., Kessels A., Weber W.E. Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: Prospective cohort study in 196 patients. BMJ Open 2013, 3:4.
10. Brooks D.J. Imaging approaches to Parkinson disease. JNucl Med 2010, 51:596-609.
11. Doepp F., Plotkin M., Siegel L., Kivi A., Gruber D., Lobsien E., Kupsch A., Schreiber S.J. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Mov Disord 2008, 23:405-410.
12. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., Kaufmann H., Klockgether T., Lang A.E., Lantos P.L., Litvan I., Mathias C.J., Oliver E., Robertson D., Schatz I., Wenning G.K. Consensus statement on the diagnosis of multiple system atrophy: American Autonomic Society and American Academy of Neurology. Clin Auton Res 1998, 8:359-362.
13. Hughes A.J., Daniel S.E., Ben-Shlomo Y., Lees A.J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125:861-870.
14. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathologic study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55:181-184.
15. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: Pathophysiologic and clinical implications. NEngl J Med 1988, 318:876-880.
16. Koch W., Radau P.E., Hamann C., Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. JNucl Med 2005, 46:1109-1118.
17. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., Goetz C.G., Golbe L.I., Grafman J., Growdon J.H., Hallett M., Jankovic J., Quinn N.P., Tolosa E., Zee D.S. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele- Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
18. Marshall V.L., Reininger C.B., Marquardt M., Patterson J., Hadley D.M., Oertel W.H., Benamer H.T., Kemp P., Burn D., Tolosa E., Kulisevsky J., Cunha L., Costa D., Booij J., Tatsch K., Chaudhuri K.R., Ulm G., Pogarell O., Höffken H., Gerstner A., Grosset D.G. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3-y European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord 2009, 24:500-508.
19. Pirker W., Djamshidian S., Asenbaum S., Gerschlager W., Tribl G., Hoffmann M., Brücke T. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal beta-CIT SPECT study. Mov Disord 2002, 17:45-53.
20. Schillaci O., Chiaravalloti A., Pierantozzi M., Di Pietro B., Koch G., Bruni C., Stanzione P., Stefani A. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: Molecular imaging with 123I-FP-CIT SPECT. Int J Mol Med 2011, 28:881-886.
21. Skoloudik D., Fadrna T., Bartova P., Langova K., Ressner P., Zapletalova O., Hluštík P., Herzig R., Kaňovský P. Reproducibility of sonographic measurement of the substantia nigra. Ultrasound Med Biol 2007, 33:1347-1352.
22. Sommer U., Hummel T., Cormann K., Mueller A., Frasnelli J., Kropp J., Reichmann H. Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography and SPECT. Mov Disord 2004, 19:1196-1202.
23. Spiegel J., Hellwig D., Mollers M.O., Behnke S., Jost W., Fassbender K., Samnick S., Dillmann U., Becker G., Kirsch C.M. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 2006, 129:1188-1193.
24. Verhoeff N.P.L.G. Imaging presynaptic dopamine synthesis in parkinsonian syndromes. Rev Bras Psiquiatr 2001, 23(Suppl I):50-52.
25. Vlaar A.M., Bouwmans A., Mess W.H., Tromp S.C., Weber W.E. Transcranial duplex in the differential diagnosis of parkinsonian syndromes: A systematic review. JNeurol 2009, 256:530-538.
26. Vlaar A.M., de Nijs T., Kessels A.G., Vreeling F.W., Winogrodzka A., Mess W.H., Tromp S.C., van Kroonenburgh M.J., Weber W.E. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT Scans in 248 patients with parkinsonian syndromes. Eur Neurol 2008, 59:258-266.
27. Vlaar A.M., de Nijs T., van Kroomenburgh M.J., Mess W.H., Winogrodzka A., Tromp S.C., Weber W.E. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: Comparison with SPECT scans. BMC Neurol 2008, 8:42.
28. Vlaar A.M., van Kroonenburgh M.J., Kessels A.G., Weber W.E. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol 2007, 7:27.
29. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G, Berg D. Transcranial brain parenchyma sonography in movement disorders: State of the art. Ultrasound Med Biol 2007, 33:15-25.
30. Walter U., Dressler D., Wolters A., Wittstock M., Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord 2007, 22:48-54.
31. Walter U., Niehaus L., Probst T., Benecke R., Meyer B.U., Dressle D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003, 60:74-77.
32. Walter U., Wittstock M., Benecke R., Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increase in Parkinson's disease. JNeural Transm 2002, 109:191-196.
33. Weise D., Lorenz R., Schliesser M., Schirbel A., Reiners K., Classen J. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Mov Disord 2009, 24:1669-1675.
34. Williams D.T., Ford B., Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. AdvNeurol 1995, 65:231-257.